Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging.

Pneumonia (Nathan) 2018 5;10. Epub 2018 Jun 5.

1Respiratory Infection Group, Liverpool School of Tropical Medicine, Liverpool, UK.

Background: The incidence of community-acquired pneumonia and lower respiratory tract infection rises considerably in later life. Immunoglobulin M (IgM) antibody levels to pneumococcal capsular polysaccharide are known to decrease with age; however, whether levels of IgM antibody to pneumococcal proteins are subject to the same decline has not yet been investigated.

Methods: This study measured serum levels and binding capacity of IgM antibody specific to the pneumococcal surface protein A (PspA) and an unencapsulated pneumococcal strain in serum isolated from hospital patients aged < 60 and ≥ 60, with and without lower respiratory tract infection. A group of young healthy volunteers was used as a comparator to represent adults at very low risk of pneumococcal pneumonia. IgM serum antibody levels were measured by enzyme-linked immunosorbent assay (ELISA) and flow cytometry was performed to assess IgM binding capacity. Linear regression and one-way analysis of variance (ANOVA) tests were used to analyse the results.

Results: Levels and binding capacity of IgM antibody to PspA and the unencapsulated pneumococcal strain were unchanged with age.

Conclusions: These findings suggest that protein-based pneumococcal vaccines may provide protective immunity in the elderly.

Trial Registration: The LRTI trial (LRTI and control groups) was approved by the National Health Service Research Ethics Committee in October 2013 (12/NW/0713). Recruitment opened in January 2013 and was completed in July 2013. Healthy volunteer samples were taken from the EHPC dose-ranging and reproducibility trial, approved by the same Research Ethics Committee in October 2011 (11/NW/0592). Recruitment for this study ran from October 2011 until December 2012. LRTI trial: (NCT01861184), EHPC dose-ranging and reproducibility trial: (ISRCTN85403723).

Download full-text PDF

Source
http://dx.doi.org/10.1186/s41479-018-0048-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987460PMC
June 2018
46 Reads

Publication Analysis

Top Keywords

igm antibody
12
proteins subject
4
pneumococcal proteins
4
antibody pneumococcal
4
subject decline
4
decline investigatedmethods
4
study measured
4
investigatedmethods study
4
levels igm
4
age levels
4
pneumococcal
4
antibody levels
4
levels pneumococcal
4
pneumococcal capsular
4
decrease age
4
capsular polysaccharide
4
measured serum
4
serum levels
4
strain serum
4
pneumococcal strain
4

References

(Supplied by CrossRef)

NK Brar et al.
Ther Adv Respir Dis 2011

ML Levy et al.
Prim Care Respir J 2010

T Welte et al.
Semin Respir Crit Care Med 2009

T van der Poll et al.
Lancet 2009

S Ewig et al.
Thorax 2009

ERC Millett et al.
PLoS One 2013

A Sliedrecht et al.
Thorax 2008

M Yamaya et al.
J Am Geriatr Soc 2001

M Svartengren et al.
Eur Respir J 2005

JC Ho et al.
Am J Respir Crit Care Med 2001

KC Meyer et al.
Respir Physiol 2001

Similar Publications